EMEA-001461-PIP01-13
Key facts
Active substance |
Acotiamide
|
Therapeutic area |
Gastroentology-Hepatology
|
Decision number |
P/0213/2013
|
PIP number |
EMEA-001461-PIP01-13
|
Pharmaceutical form(s) |
Coated tablet
|
Condition(s) / indication(s) |
Treatment of functional dyspepsia
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
Zeria Pharmaceutical Co Ltd
tomoharu-miyagawa@zeria.co.jp
Tel. +44 (0)7528 697428 |
Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|